Key result
Second-generation DES yields distinct neointimal characteristics vs BMS in STEMI, with evagination linked to positive remodeling.
Why the study?
Do second-generation drug-eluting stents compared to bare-metal stents alter neointimal tissue characteristics in patients with STEMI at 9 months?
Observational (n=88)
Do second-generation drug-eluting stents compared to bare-metal stents alter neointimal tissue characteristics in patients with STEMI at 9 months?
Neointimal tissue characteristics assessed by OCT differ significantly among bare-metal and various second-generation drug-eluting stents at 9 months post-STEMI, which may influence the risk of late stent thrombosis or restenosis.
Neointimal differences after second-generation DES versus BMS in STEMI should not alter stent choice; hypothesis-generating for late thrombosis risk.
Background: Neointimal tissue characteristics after implantation of stents are related to late/ very late stent thrombosis and/ or restenosis of target lesion. However, the difference of them has not been fully elucidated among bare-metal stents (BMS) and second-generation drug-eluting stents (DES). Methods: The present study uses optical coherence tomography (OCT) to compare neointimal tissue characteristics among BMS (n = 22), Endeavor zotarolimus - (E-ZES; n = 21), everolimus - (EES; n = 22) and biolimus A9 - (BES; n = 23) eluting stents in the patients with STEMI who underwent follow-up coronary angiography at nine months after stent implantation. Results: Quantitative coronary angiography revealed significantly higher restenosis rates for BMS and E-ZES than EES and BES. OCT showed significantly lower and higher rates for covered and uncovered EES, respectively, than for BMS and E-ZES. The malapposition rate for E-ZES was significantly lower than those of other two types of DES. The neointima of EES and BES was significantly thinner than that of BMS and E-ZES. Evagination was more prevalent in BES among the four stents, and the rate of evagination/strut significantly correlated with positive remodeling (r = 0.312, p = 0.006). Conclusion: Neointimal tissue characteristics were different among BMS and second-generation DES at nine months after implantation into patients with STEMI. This might be related to the differences of future cardiac events.
No takes yet. Share an insight, caveat, or question.
Sonoda et al. (2016) conducted an observational in ST-segment Elevation Myocardial Infarction (STEMI) (n=88). Second-generation drug-eluting stents (E-ZES, EES, BES) vs. Bare-metal stents (BMS) was evaluated on Neointimal tissue characteristics assessed by optical coherence tomography. Second-generation drug-eluting stents and bare-metal stents showed different neointimal characteristics at 9 months in STEMI patients, with evagination per strut correlating with positive remodeling (r=0.312, p=0.006).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: